TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 103 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $12,283,000 | +7.2% | 79,478 | -0.9% | 0.85% | +14.2% |
| Q3 2015 | $11,463,000 | -9.0% | 80,220 | -8.5% | 0.74% | +10.5% |
| Q2 2015 | $12,600,000 | -27.6% | 87,686 | -28.9% | 0.67% | -15.8% |
| Q1 2015 | $17,392,000 | +29.8% | 123,324 | +36.4% | 0.80% | +29.7% |
| Q4 2014 | $13,395,000 | – | 90,393 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |